From histones to ribosomes: A chromatin regulator tangoes with translation

Cancer Discovery

Volumn 5, Issue 3, 2015, Pages 228-230

  Rothbart, Scott B ^a   Dickson, Bradley M ^b   Strahl, Brian D ^b,c  

^a VAN ANDEL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEMETHYLASE; INITIATION FACTOR 4E BINDING PROTEIN; LYSINE DEMETHYLASE KDM4A; LYSINE METHYLTRANSFERASE; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; METHYLTRANSFERASE; PROTEIN TYROSINE KINASE; S6 KINASE; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; KDM4A PROTEIN, HUMAN; LYSINE; PROTEIN KINASE INHIBITOR; TARGET OF RAPAMYCIN KINASE;

ARTICLE; CELLULAR DISTRIBUTION; HISTONE METHYLATION; HUMAN; IMMUNOPRECIPITATION; MASS SPECTROMETRY; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; PROTEOMICS; RIBOSOME; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION; TRANSLATION INITIATION; TRANSLATION REGULATION; UBIQUITINATION; ANTAGONISTS AND INHIBITORS; DRUG RESISTANCE; GENETICS; METABOLISM; OPEN READING FRAME;

ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, NEOPLASM; HUMANS; JUMONJI DOMAIN-CONTAINING HISTONE DEMETHYLASES; LYSINE; OPEN READING FRAMES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN BIOSYNTHESIS; PROTEIN KINASE INHIBITORS; TOR SERINE-THREONINE KINASES;

EID: 84925296506     PISSN: 21598274     EISSN: 21598290     Source Type: Journal    
DOI: 10.1158/2159-8290.CD-15-0073     Document Type: Article

References (10)

1. Lee DY, Teyssier C, Strahl BD, Stallcup MR. Role of protein methyla-tion in regulation of transcription. Endocr Rev 2005;26:147–70.
2. Greer EL, Shi Y. Histone methylation: a dynamic mark in health, disease and inheritance. Nat Rev Genet 2012;13:343–57.
3. Petrossian TC, Clarke SG. Uncovering the human methyltransfera-some. Mol Cell Proteomics 2011;10:M110 000976.
4. Kooistra SM, Helin K. Molecular mechanisms and potential functions of histone demethylases. Nat Rev Mol Cell Biol 2012;13:297-311.
5. Klose RJ, Yamane K, Bae Y, Zhang D, Erdjument-Bromage H, Tempst P, et al. The transcriptional repressor JHDM3A demethylates trime-thyl histone H3 lysine 9 and lysine 36. Nature 2006;442:312–6.
6. Whetstine JR, Nottke A, Lan F, Huarte M, Smolikov S, Chen Z, et al. Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell 2006;125:467–81.
7. Black JC, Manning AL, Van Rechem C, Kim J, Ladd B, Cho J, et al. KDM4A lysine demethylase induces site-specifi c copy gain and rerep-lication of regions amplified in tumors. Cell 2013;154:541–55.
8. Van Rechem C, Black JC, Boukhali M, Aryee MJ, Gräslund S, Haas W, et al. Lysine demethylase KDM4A associates with translation machinery and regulates protein synthesis. Cancer Discov 2015;5:255–63.
9. Van Rechem C, Black JC, Greninger P, Zhao Y, Donado C, Bur-rowes PD, et al. A coding single-nucleotide polymorphism in lysine demethylase KDM4A associates with increased sensitivity to mTOR inhibitors. Cancer Discov 2015;5:245–54.
10. Moore KE, Gozani O. An unexpected journey: lysine methylation across the proteome. Biochim Biophys Acta 2014;1839:1395–403.